Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Angela Kerins"'
Publikováno v:
Addiction Science & Clinical Practice, Vol 18, Iss 1, Pp 1-8 (2023)
Abstract Background Hospitalizations are a vital opportunity for the initiation of life-saving opioid agonist therapy (OAT) for patients with opioid use disorder. A novel approach to OAT initiation is the use of IV buprenorphine for low dose inductio
Externí odkaz:
https://doaj.org/article/186feda06b114131af7638f8704766bf
Publikováno v:
Academic Medicine. 98:S25-S27
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3282a67d47a77177de57a17c76187c38
https://doi.org/10.1097/acm.0000000000005184
https://doi.org/10.1097/acm.0000000000005184
Publikováno v:
Journal of the American Pharmacists Association : JAPhA.
Hospitalized patients with opioid use disorder (OUD) present unique challenges and opportunities for inpatient medical teams. Having the ability to initiate medications for opioid use disorder (MOUD) and linkage to outpatient treatment are key to imp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::88ece51532f5c0371ff1fb697b514900
https://pubmed.ncbi.nlm.nih.gov/36115762
https://pubmed.ncbi.nlm.nih.gov/36115762
Autor:
Angela Kerins, John P Murray
Publikováno v:
Oxford Medical Case Reports
Amantadine withdrawal syndrome (AWS) is a rare but recognized cause of severe and persistent altered mental status sometimes with co-occurring extrapyramidal symptoms. First described in a case series from 1987, its clinical manifestations have been
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bd019186790e2d0a9e2ac60e419e9f6e
http://europepmc.org/articles/PMC7885144
http://europepmc.org/articles/PMC7885144